Oramed Pharmaceuticals
ORMP
ORMP
54 hedge funds and large institutions have $31.4M invested in Oramed Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5.26% more ownership
Funds ownership: 22.46% → 27.72% (+5.3%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
54
Holding in Top 10
2
Calls
$19K
Puts
–
Top Buyers
| 1 | +$668K | |
| 2 | +$217K | |
| 3 | +$119K | |
| 4 |
QC
Quadrature Capital
London,
United Kingdom
|
+$108K |
| 5 |
Squarepoint
New York
|
+$73.3K |
Top Sellers
| 1 | -$1.06M | |
| 2 | -$602K | |
| 3 | -$50.3K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$28K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$19.1K |
